2 transcripts
DYAI
Earnings call transcript
NASDAQ
2024 Q2
13 Aug 24
and growth by pushing the boundaries of innovation and accelerating commercialization. We are expanding the use of our C1 and databus microbial protein
DYAI
Earnings call transcript
NASDAQ
2024 Q1
14 May 24
by our strategic partnership with Rabian BV a Dutch innovative SME founded by seasoned entrepreneurs and vaccine scientists. Rabian secured EUR 8.7 million
- Prev
- 1
- Next